Quick Answer
Forte Biosciences, Inc. reported Total Revenue of $36.0 thousand for fiscal year 2019.
Forte Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2019 | $36.0K | -99.8% |
| 2018 | $18.04M | +43890.2% |
| 2017 | $41.0K | -16.3% |
| 2016 | $49.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $9.0K | -100.0% | +0.0% |
| June 30, 2019 | $9.0K | +0.0% | +0.0% |
| March 31, 2019 | $9.0K | +0.0% | -100.0% |
| September 30, 2018 | $18.01M | +179990.0% | +200000.0% |
| June 30, 2018 | $9.0K | -10.0% | +0.0% |
| March 31, 2018 | $9.0K | — | -10.0% |
| September 30, 2017 | $10.0K | — | +0.0% |
| June 30, 2017 | $10.0K | — | — |
- Forte Biosciences, Inc. showed a decrease of -99.8% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2019 period, Forte Biosciences, Inc.’s total revenue has declined by 26.5% (from $49.0 thousand to $36.0 thousand).
- The most recent figure is from Forte Biosciences, Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on February 27, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: